Decrease in Quality of Life and Functional Assessment in Elder Patients with End-Stage Renal Disease after Two Years of Hemodialysis Therapy

Journal Title: Open Access Journal of Urology & Nephrology - Year 2019, Vol 4, Issue 2

Abstract

Introduction: Hemodialysis improves survival rates of Chronic Kidney Disease (CKD) patients but not Quality of Life (QoL) which decreases in a more aggressive way in the elderly population. We describe the reduction and impact in QoL and functional assessment at 6 months, 1 and 2-years of treatment in hemodialysis. Methods: We performed a single center prospective study, applying the Kidney Disease Quality of Life (KDOQOL-36 TM) in Spanish, Katz Index, Barthel Index, Lawton and Brody Scale and Karnofsky Performance Status to patients with CKD KDIGO 5D, aged 65 years or older at our hemodialysis center on October 2016. During the study, patients received hemodialytic and pharmacological treatment. We applied the surveys again on May 2017, October 2017 and October 2018 to the same population. Results were presented using mean and standard deviation and were analyzed using a Student’s t-test. Results: At the beginning of the study 22 elder patients in hemodialysis were included, 59% of them were men with an average age of 72.9 (±5.9) years, and an average time in hemodialysis of 27.1 (±24.1) months. After a two-year follow up 36% of the patients died, 9% changed their residency and 55% remained active at our center. We compared the media of each subscale after six months, one and two years with Student’s t-test, finding a significant decrease only at the 2-years evaluation in Effects and Burden of kidney disease subscales compared with the previous ones (p<0.01), but no difference on the rest of subscales. Conclusion: We observed a decrease in all subscales of KDOQOL-36TM and functional assessment evaluation with statistical difference in the Effects and Burden of kidney disease subscales at the second year. The decrease was not as pronounced as expected, possibly because the patients who died probably had the lowest scores at the beginning of the study.

Authors and Affiliations

David Escamilla-Illescas

Keywords

Related Articles

Prevalence Patterns of Chronic Kidney Disease among SchoolChildren and Adolescents in a School in Varanasi, India

Background: Chronic kidney disease is relatively uncommon in children but can be a devastating illness with several long-term consequences. There is no consensus on the utility of screening programs of chronic kidney dis...

Acute Renal Failure in an HIV Patient: The Importance of Antiretroviral Treatment and Concomitant Medications

Antiretroviral treatment has significant side effects, including wasting syndrome, lipodystrophy and kidney damage. The authors present a 49-years female patient who developed acute renal failure after the intake of NSAI...

Paratesticular Masson’s Hemangioma Case Report and Review of the Literature

Masson’s hemangioma or intravascular papillary endothelial hyperplasia is a rare intravascular benign lesion. It may involve a wide variety of organs, most frequently the skin and subcutaneous tissue. Regarding the uroge...

Application of PSA Kinetics on Prostate Cancer: Experience of Pharmacovigilance Department of University Hospital Establishment of ORAN (UHE) in Algeria

Many international studies have shown the interest of prostate specific antigen (PSA) in prostate cancer monitoring, although it is not very specific to this pathology, it remains the best marker for the evaluation of pr...

Diabetic Kidney Disease: A New Concept for an Old Problem

Diabetes Mellitus (DM) is a growing worldwide epidemic. It was estimated that more than 366 million people would be affected. DM has spread its presence over the world due to lifestyle changes, increasing obesity and eth...

Download PDF file
  • EP ID EP521212
  • DOI -
  • Views 42
  • Downloads 0

How To Cite

David Escamilla-Illescas (2019). Decrease in Quality of Life and Functional Assessment in Elder Patients with End-Stage Renal Disease after Two Years of Hemodialysis Therapy. Open Access Journal of Urology & Nephrology, 4(2), 1-6. https://europub.co.uk./articles/-A-521212